Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-06-22 08:14 am Sale | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 0 0% | -12,962,100![]() (Position Closed) | View |
2020-09-16 4:56 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 12,962,100 97.9% | 1,200,100![]() (+10.20%) | View |
2020-08-20 4:50 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 11,762,000 97.7% | 14,498![]() (+0.12%) | View |
2020-04-01 4:22 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 11,747,502 98.8% | 1,227,295![]() (+11.67%) | View |
2020-02-10 3:17 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 10,249 2.9% | 10,249![]() (New Position) | View |
2020-01-21 2:28 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | SABBY MANAGEMENT, LLC | 106 11% | 106![]() (New Position) | View |
2019-11-18 5:16 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 10,520,207 98.4% | 10,520,207![]() (New Position) | View |
2019-10-01 4:15 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | BIGGER CAPITAL FUND L P | 335,800,000 9.9% | 83,400,000![]() (+33.04%) | View |
2019-09-30 5:28 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 252,630,682 92.2% | 8,068,858![]() (+3.30%) | View |
2019-06-24 4:13 pm Purchase | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL, LLC | 244,561,824 94.9% | 244,561,824![]() (New Position) | View |
2019-06-21 5:01 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | BIGGER CAPITAL FUND L P | 252,400,000 9.9% | 170,000,000![]() (+206.31%) | View |
2019-06-20 4:45 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | BIGGER CAPITAL FUND L P | 82,400,000 9.9% | 82,400,000![]() (New Position) | View |
2019-02-14 1:40 pm Sale | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 805,771 9.9% | -5,585![]() (-0.69%) | View |
2019-02-14 09:25 am Purchase | 13G | ReShape Lifesciences Inc. RSLS | SVLSF IV, LLC | 1,072 0.1% | 1,072![]() (New Position) | View |
2019-02-08 1:40 pm Sale | 13G | ReShape Lifesciences Inc. RSLS | INTRACOASTAL CAPITAL, LLC | 4,765 0.1% | -534,081![]() (-99.12%) | View |
2019-02-07 8:14 pm Sale | 13G | ReShape Lifesciences Inc. ETRM | US VENTURE PARTNERS X LP | 1,505 0% | -2,826,849![]() (-99.95%) | View |
2019-01-07 12:20 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | SABBY MANAGEMENT, LLC | 876,156 11% | 876,156![]() (New Position) | View |
2018-12-04 5:41 pm Purchase | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 811,356 9.9% | 811,356![]() (New Position) | View |
2018-10-12 3:59 pm Sale | 13G | ReShape Lifesciences Inc. ETRM | Endeavour Medtech Growth L.P. | 0 0% | -3,421,641![]() (Position Closed) | View |
2018-10-05 4:19 pm Unchanged | 13D | ReShape Lifesciences Inc. RSLS | HealthCor Partners Management LP | 349,139 0.4% | 0 (Unchanged) | View |